Search Results - Moehler, Markus
- Showing 1 - 20 results of 70
- Go to Next Page
-
1
Immunotherapy in Gastric Cancer by Högner, Anica, Moehler, Markus
Published 2022Text -
2
-
3
-
4
-
5
-
6
-
7
-
8
Influence of the oncolytic parvovirus H-1, CTLA-4 antibody tremelimumab and cytostatic drugs on the human immune system in a human in vitro model of colorectal cancer cells by Heinrich, Bernd, Goepfert, Katrin, Delic, Maike, Galle, Peter R, Moehler, Markus
Published 2013Text -
9
-
10
Immune checkpoint inhibitors plus chemotherapy versus chemotherapy or immune checkpoint inhibitors for first‐ or second‐line treatment of advanced gastric and gastro‐esophageal jun... by Özdemir, Berna C, Moehler, Markus, Syn, Nicholas LX, Tai, Bee‐Choo, Wagner, Anna Dorothea
Published 2019Text -
11
-
12
Survival after chemotherapy and/or radiotherapy versus self-expanding metal stent insertion in the setting of inoperable esophageal cancer: a case-control study by Sgourakis, George, Gockel, Ines, Karaliotas, Constantine, Moehler, Markus, Schimanski, Carl Christoph, Schmidberger, Heinz, Junginger, Theodor
Published 2012Text -
13
Combination therapies with oxaliplatin and oral capecitabine or intravenous 5-FU show similar toxicity profiles in gastrointestinal carcinoma patients if hand-food syndrome prophyl... by WEHLER, THOMAS C., CAO, YANG, GALLE, PETER R., THEOBALD, MATTHIAS, MOEHLER, MARKUS, SCHIMANSKI, CARL C.
Published 2012Text -
14
-
15
-
16
Any progress in informed consenting for cancer treatment? Results from a cross sectional analysis at a comprehensive cancer center by Schwaegermann, Marie-Kristin, Schranz, Melanie, Moehler, Markus, Labenz, Christian, Moringlane, Alice, Schmidt, Marcus, Theobald, Matthias, Hess, Georg
Published 2021Text -
17
-
18
VEGF-D expression correlates with colorectal cancer aggressiveness and is downregulated by cetuximab by Moehler, Markus, Frings, Christian, Mueller, Annett, Gockel, Ines, Schimanski, Carl C, Biesterfeld, Stefan, Galle, Peter R, Holtmann, Martin H
Published 2008Text -
19
Activation of the human immune system by chemotherapeutic or targeted agents combined with the oncolytic parvovirus H-1 by Moehler, Markus, Sieben, Maike, Roth, Susanne, Springsguth, Franziska, Leuchs, Barbara, Zeidler, Maja, Dinsart, Christiane, Rommelaere, Jean, Galle, Peter R
Published 2011Text -
20
Advances in the endoscopic management of malignant biliary obstruction by Thomaidis, Thomas, Kallimanis, George, May, Gary, Zhou, Pinghong, Sivanathan, Visvakanth, Mosko, Jeff, Triantafillidis, John K., Teshima, Christopher, Moehler, Markus
Published 2020Text